https://www.biospace.com/genfit-announces-fda-protocol-clearance-for-phase-2-clinical-trial-of-elafibranor-in-pediatric-nash
FDA accepts study protocol, providing green light for GENFIT to initiate Phase 2 clinical trial in pediatric NASH
clinical trialannouncesfdaprotocolclearance
https://www.newswire.com/news/fhi-clinical-to-write-clinicat-trial-protocol-for-gb-sciences-21698209
Plant-inspired biopharmaceutical company signs leading contract research organization to help with a go-to-market strategy for its cannabinoid-containing...
fhiclinicalwritetrialprotocol